Paper21245274
Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis.
Jarchum I and 3 others. Infect Immun, 2011. Cited by 118 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Papers, record 21245274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21245274
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clostridioides difficile | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Toll-Like Receptor 5 | Major topic |
| Acute Disease | |
| Animals | |
| Disease Models, Animal | |
| Female | |
| Flagellin | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI042135 | NIAID NIH HHS | United States | R01AI042135 | PubMed and NIH | NIH RePORTER |
| R01 AI095706 | NIAID NIH HHS | United States | R01AI095706 | PubMed and NIH | NIH RePORTER |
| R37 AI039031 | NIAID NIH HHS | United States | R37AI039031 | PubMed and NIH | NIH RePORTER |
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,523,294 | Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. | J Immunol | 2008 | https://conductscience.org/library/papers/18523294 | PubMed |
| 2 | 10,772,660 | p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10772660 | PubMed |
| 3 | 11,179,295 | Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. | Infect Immun | 2001 | https://conductscience.org/library/papers/11179295 | PubMed |
| 4 | 1,910,012 | Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B. | Infect Immun | 1991 | https://conductscience.org/library/papers/1910012 | PubMed |
| 5 | 10,784,054 | A Clostridium difficile gene encoding flagellin. | Microbiology (Reading) | 2000 | https://conductscience.org/library/papers/10784054 | PubMed |
| 6 | 15,260,992 | Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. | Cell | 2004 | https://conductscience.org/library/papers/15260992 | PubMed |
| 7 | 11,489,966 | Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. | J Immunol | 2001 | https://conductscience.org/library/papers/11489966 | PubMed |
| 8 | 18,724,361 | Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. | Nature | 2008 | https://conductscience.org/library/papers/18724361 | PubMed |
| 9 | 18,971,494 | Clostridium difficile--more difficult than ever. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18971494 | PubMed |
| 10 | 6,776,012 | Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. | Gut | 1980 | https://conductscience.org/library/papers/6776012 | PubMed |
| 11 | 20,643,849 | Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection. | Infect Immun | 2010 | https://conductscience.org/library/papers/20643849 | PubMed |
| 12 | 19,833,089 | The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. | Immunity | 2009 | https://conductscience.org/library/papers/19833089 | PubMed |
| 13 | 20,566,829 | Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. | J Immunol | 2010 | https://conductscience.org/library/papers/20566829 | PubMed |
| 14 | 18,264,109 | Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. | Nat Med | 2008 | https://conductscience.org/library/papers/18264109 | PubMed |
| 15 | 19,324,080 | Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages. | Microb Pathog | 2009 | https://conductscience.org/library/papers/19324080 | PubMed |
| 16 | 16,829,963 | Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. | Nat Immunol | 2006 | https://conductscience.org/library/papers/16829963 | PubMed |
| 17 | 9,784,558 | Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis. | Infect Immun | 1998 | https://conductscience.org/library/papers/9784558 | PubMed |
| 18 | 20,844,489 | The role of toxin A and toxin B in Clostridium difficile infection. | Nature | 2010 | https://conductscience.org/library/papers/20844489 | PubMed |
| 19 | 19,564,350 | STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. | J Exp Med | 2009 | https://conductscience.org/library/papers/19564350 | PubMed |
| 20 | 7,907,603 | Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. | J Clin Invest | 1994 | https://conductscience.org/library/papers/7907603 | PubMed |
Cited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,542,579 | High-fat diet rewires gut host-microbiota relationship to derive worse outcomes following Clostridioides difficile infection. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542579 | PubMed |
| 41,539,854 | Attenuation of Clostridioides difficile Infection by Clostridium hylemonae. | J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/41539854 | PubMed |
| 41,158,525 | Mechanisms of Clostridioides difficile glucosyltransferase toxins and their roles in pathology: insights and emerging therapeutic strategies. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41158525 | PubMed |
| 39,472,390 | Large Clostridial Toxins: A Brief Review and Insights into Antigen Design for Veterinary Vaccine Development. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/39472390 | PubMed |
| 39,458,243 | A Mouse Model of Mild Clostridioides difficile Infection for the Characterization of Natural Immune Responses. | Microorganisms | 2024 | https://conductscience.org/library/papers/39458243 | PubMed |
| 39,349,385 | Progranulin protects against Clostridioides difficile infection by enhancing IL-22 production. | Gut Microbes | 2024 | https://conductscience.org/library/papers/39349385 | PubMed |
| 38,526,073 | Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/38526073 | PubMed |
| 38,396,876 | Clostridioides difficile Flagella. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396876 | PubMed |
| 38,133,438 | Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches. | Trop Med Infect Dis | 2023 | https://conductscience.org/library/papers/38133438 | PubMed |
| 38,089,944 | Molecular Insights Into the Role of Gut Microbiota in Antibiotic Therapy Selection and Resistance Mitigation. | Cureus | 2023 | https://conductscience.org/library/papers/38089944 | PubMed |
| 37,937,304 | Microbiota in cancer: molecular mechanisms and therapeutic interventions. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37937304 | PubMed |
| 36,939,332 | Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection. | Infect Immun | 2023 | https://conductscience.org/library/papers/36939332 | PubMed |
| 36,651,798 | Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation. | Inflamm Bowel Dis | 2023 | https://conductscience.org/library/papers/36651798 | PubMed |
| 36,014,040 | Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements. | Microorganisms | 2022 | https://conductscience.org/library/papers/36014040 | PubMed |
| 34,992,590 | Host Immune Responses to Clostridioides difficile: Toxins and Beyond. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34992590 | PubMed |
| 34,644,311 | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneumoniae during influenza virus infection in human monocytes. | PLoS One | 2021 | https://conductscience.org/library/papers/34644311 | PubMed |
| 34,322,122 | The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients. | Front Immunol | 2021 | https://conductscience.org/library/papers/34322122 | PubMed |
| 34,244,557 | In silico designing of vaccine candidate against Clostridium difficile. | Sci Rep | 2021 | https://conductscience.org/library/papers/34244557 | PubMed |
| 33,785,619 | Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant. | mBio | 2021 | https://conductscience.org/library/papers/33785619 | PubMed |
| 33,718,269 | Leptin Receptor q223r Polymorphism Influences Clostridioides difficile Infection-Induced Neutrophil CXCR2 Expression in an Interleukin-1β Dependent Manner. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/33718269 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TLR5 | 7,100 | PubTator's text mining | https://conductscience.org/library/genes/7100 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21245274
GET https://conductscience.org/api/papers/v1/21245274/references?page=2